Novartis first-half results beat analysts' expectations
Article Abstract:
Novartis AG posted stronger-than-expected growth in first-half net income but company executives were cautious about prospects for the full year, stating that there would likely be a slowdown in drug-division sales during the current quarter. The company's first-half net increased 12% to 4.19 billion Swiss francs (Euro2.69 billion) from 3.74 billion francs a year earlier. Sales increased 15%, from 16.49 billion francs to 18.96 billion francs.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Analysts see weak spots at Novartis
Article Abstract:
Novartis AG posted an improvement of 5% in its net income for the first-half of 1999. The figure was higher-than-expected. However, analysts noticed data that showed that the company had a weaker-than-believed underlying performance after extraordinary and one-time items. Novartis posted 3.73 billion Swiss francs (2.33 billion euros) in the half. During the same period in 1998, the firm posted 3.55 billion Swiss francs.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Novartis posts sales slide, warns of profit slowdown
Article Abstract:
Novartis AG posted weak sales for the first quarter of 1999. The Swiss-based drug, seed, and chemical firm also cautioned that its earnings will see slower growth for the 1999 year compared to the 1998 year. Novartis posted 7.87 billion Swiss francs ($5.22 billion) in quarterly sales. During the same period in 1998, the company posted 7.92 billion Swiss francs in sales.
Comment:
Posts weak sales for first quarter of 1999
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Sears Roebuck beats forecasts as provisions fall. Weak sales force Sears to lower profit forecast. Sears Roebuck posts 61% rise in 1st-quarter net
- Abstracts: Akzo's net falls 7% but beats estimates. Akzo Nobel posts a 30% profit rise for first-quarter. Akzo likely to post a modest increase in 1999 net profit
- Abstracts: Fannie Mae reports 17% net increase, beating forecasts. Fannie Mae's net surges on back of refinancings. Two key lenders in U.S. draw ire from many corners
- Abstracts: Turkish surprise: A business blazes path for nation to EU's doorstep. Kazakhstan struggle sparked U.S. probe
- Abstracts: Sainsbury shares drop 18% on fall in pretax profit. Tesco's pretax profit jumps 12% as move into nonfoods pays